chrX-18646076-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BS1BS2_SupportingBP4
This summary comes from the ClinGen Evidence Repository: RS1(NM_000330.4) and an alternative transcript of CDKL5 (NM_003159.2) are overlapping transcripts; however, these variants are in the noncoding 3' region of the main CDKL5 transcript (NM_001323289.2). The c.2783C>T (p.Thr928Met) variant in CDKL5 transcript (NM_003159.2) (RS1 c.326+1115G>A) is 0.0188% in African sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Thr928Met variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). Additionally, the p.Thr928Met variant is observed in at least 1 unaffected individual (PMID:31209962) (BS2_supporting). In summary, the p.Thr928Met variant in CDKL5 (NM_003159.2) is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4, BS2_supporting). LINK:https://erepo.genome.network/evrepo/ui/classification/CA327012012/MONDO:0100039/034
Frequency
Consequence
NM_003159.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.326+1115G>A | intron_variant | ENST00000379984.4 | NP_000321.1 | |||
CDKL5 | NM_001037343.2 | c.2783C>T | p.Thr928Met | missense_variant | 20/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.2783C>T | p.Thr928Met | missense_variant | 19/21 | NP_003150.1 | ||
RS1 | XM_047442337.1 | c.230+1115G>A | intron_variant | XP_047298293.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000379989.6 | c.2783C>T | p.Thr928Met | missense_variant | 20/22 | 1 | ENSP00000369325.3 | |||
CDKL5 | ENST00000379996.7 | c.2783C>T | p.Thr928Met | missense_variant | 19/21 | 1 | ENSP00000369332.3 | |||
RS1 | ENST00000379984.4 | c.326+1115G>A | intron_variant | 1 | NM_000330.4 | ENSP00000369320.3 | ||||
RS1 | ENST00000476595.1 | n.817+1115G>A | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111856Hom.: 0 Cov.: 22 AF XY: 0.0000587 AC XY: 2AN XY: 34046
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 181634Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67396
GnomAD4 exome AF: 0.0000455 AC: 50AN: 1098173Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 13AN XY: 363527
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111856Hom.: 0 Cov.: 22 AF XY: 0.0000587 AC XY: 2AN XY: 34046
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
CDKL5 disorder Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Feb 20, 2023 | RS1(NM_000330.4) and an alternative transcript of CDKL5 (NM_003159.2) are overlapping transcripts; however, these variants are in the noncoding 3' region of the main CDKL5 transcript (NM_001323289.2). The c.2783C>T (p.Thr928Met) variant in CDKL5 transcript (NM_003159.2) (RS1 c.326+1115G>A) is 0.0188% in African sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Thr928Met variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). Additionally, the p.Thr928Met variant is observed in at least 1 unaffected individual (PMID: 31209962) (BS2_supporting). In summary, the p.Thr928Met variant in CDKL5 (NM_003159.2) is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4, BS2_supporting). - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at